SUN Rises from RANBAXY: Supply Chain Strategy of an Indian Pharmaceutical Company

Manikandan, Sushmera; Sundarakani, Balan

doi:10.1007/978-981-13-1399-8_11

Cited by 1 publication

(1 citation statement)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, these strategies are not always fully used, as they are constantly criticized and should be examined [ 48 ]. Moreover, all of these strategies are associated with some risks, which must be considered to prevent SC disruption [ 19 , 49 ].…”

Section: Literature Reviewmentioning

confidence: 99%

System dynamics model for an agile pharmaceutical supply chain during COVID‑19 pandemic in Iran

Hamzehlou

2024

PLoS ONE

View full text Add to dashboard Cite

Unpredictable changes in the current business environment have made organizations pay attention to the concept of agility. This concept is a key feature to survive and compete in turbulent markets while considering customers’ fluctuating needs. An organization’s agility is a function of its supply chain’s agility. The present study offers a System Dynamics (SD) model for Iran’s Pharmaceutical Supply Chain (PSC). The model is presented in three steps. First, the Supply Chain (SC) indicators were extracted based on theoretical foundations and literature review results. Second, an SD model of the PSC was extracted in the context of the COVID‑19 pandemic with the necessary analyses. Finally, the desired outputs and strategies were obtained by conducting a case study. The results indicated that the PSC’s highest agility could be guaranteed by the simultaneous implementation of three strategies: investment, Human Capital Development (HCD), and accelerated completion of ongoing projects on a priority basis. According to these results, the organization had better determine the amount of capital and workforce required for ongoing projects, then design funding solutions to implement these projects and implement them according to the projects’ priority.

show abstract

Section: Literature Reviewmentioning

confidence: 99%

System dynamics model for an agile pharmaceutical supply chain during COVID‑19 pandemic in Iran

Hamzehlou

2024

PLoS ONE

View full text Add to dashboard Cite

show abstract

SUN Rises from RANBAXY: Supply Chain Strategy of an Indian Pharmaceutical Company

Cited by 1 publication

References 8 publications

System dynamics model for an agile pharmaceutical supply chain during COVID‑19 pandemic in Iran

System dynamics model for an agile pharmaceutical supply chain during COVID‑19 pandemic in Iran

Contact Info

Product

Resources

About